CP
AMGN icon

Cinque Partners’s Amgen AMGN Stock Holding History

Cinque Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,858
Closed -$672K – 25
2015
Q3 		$672K Hold
4,858
– – 1.14% 27
2015
Q2 		$746K Buy
4,858
+901
+23% +$144K 1.16% 31
2015
Q1 		$633K Sell
3,957
-6,194
-61% -$976K 0.97% 35
2014
Q4 		$1.62M Sell
10,151
-5,807
-36% -$905K 0.96% 32
2014
Q3 		$2.24M Buy
15,958
+92
+0.6% +$12K 1.18% 27
2014
Q2 		$1.88M Buy
15,866
+240
+2% +$27.8K 0.97% 35
2014
Q1 		$1.93M Sell
15,626
-1,680
-10% -$204K 1.05% 32
2013
Q4 		$1.97M Buy
17,306
+2,848
+20% +$324K 1.01% 35
2013
Q3 		$1.62M Sell
14,458
-1,983
-12% -$215K 1.08% 32
2013
Q2 		$1.62M Buy
+16,441
New +$1.71M 0.98% 38

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cinque Partners's AMGN Position: Q4 2015 in Review

Cinque Partners sold out of Amgen (AMGN) in Q4 2015, closing a stake of 4,858 shares — an estimated $672K sold.

Cinque Partners first reported a position in AMGN in Q2 2013 and held it in 10 quarters. The position peaked at $2.24M in Q3 2014. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Cinque Partners reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • Cinque Partners sold 4,858 Amgen shares in Q4 2015, an estimated $672K.
  • Cinque Partners first reported a position in Amgen in Q2 2013 and held it in 10 quarters.
  • Cinque Partners's Amgen position peaked at $2.24M in Q3 2014.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Cinque Partners's 13F filing for Q4 2015, filed 12 Feb 2016.